Journal of Clinical Hypertension

metrics 2024

Fostering Collaboration for Cardiovascular Excellence

Introduction

Journal of Clinical Hypertension, published by WILEY, is a leading open-access journal focused on advancing the understanding and treatment of hypertension and related cardiovascular conditions. With an ISSN of 1524-6175 and an E-ISSN of 1751-7176, the journal provides a vital platform for researchers, healthcare professionals, and students alike to disseminate high-quality, peer-reviewed research. Since transitioning to open access in 2021, it has increased its reach and accessibility, ensuring critical information is available to a broader audience. The journal holds an impressive position in the Scopus ranks, nestled within the Q2 quartile across key disciplines including Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, and Internal Medicine, indicating a strong impact on the scientific community. With articles converging from 2001 to 2024, it not only highlights contemporary developments but also contributes to the ongoing dialogue in the field. Researchers are encouraged to submit their findings on hypertension, treatment methodologies, and epidemiology to further enhance the collective knowledge in this crucial area of health.

Metrics 2024

SCIMAGO Journal Rank0.71
Journal Impact Factor2.70
Journal Impact Factor (5 years)3.10
H-Index81
Journal IF Without Self2.70
Eigen Factor0.01
Normal Eigen Factor1.52
Influence0.88
Immediacy Index0.50
Cited Half Life5.60
Citing Half Life6.90
JCI0.56
Total Documents4286
WOS Total Citations5569
SCIMAGO Total Citations23291
SCIMAGO SELF Citations2236
Scopus Journal Rank0.71
Cites / Document (2 Years)2.49
Cites / Document (3 Years)2.38
Cites / Document (4 Years)2.33

Metrics History

Rank 2024

Scopus

Cardiology and Cardiovascular Medicine in Medicine
Rank #88/387
Percentile 77.26
Quartile Q1
Internal Medicine in Medicine
Rank #45/167
Percentile 73.05
Quartile Q2
Endocrinology, Diabetes and Metabolism in Medicine
Rank #93/244
Percentile 61.89
Quartile Q2

IF (Web Of Science)

PERIPHERAL VASCULAR DISEASE
Rank 34/96
Percentile 65.10
Quartile Q2

JCI (Web Of Science)

PERIPHERAL VASCULAR DISEASE
Rank 43/96
Percentile 55.21
Quartile Q2

Quartile History

Similar Journals

HYPERTENSION

Empowering professionals with cutting-edge findings.
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: 0194-911XFrequency: 12 issues/year

HYPERTENSION, published by Lippincott Williams & Wilkins, is a preeminent journal in the field of cardiovascular medicine, focusing on the latest research, therapies, and clinical practices related to hypertension and its associated disorders. With a distinguished Q1 ranking in Internal Medicine and a commendable Scopus rank of #12 out of 167 in its category, it occupies a vital position within the academic community, appealing to researchers, clinicians, and educators alike. The journal has been disseminating impactful findings since 1979 and continues to influence the discourse on hypertension through rigorous peer-reviewed articles, reviews, and studies designed to elevate understanding and treatment of this prevalent condition. HYPERTENSION remains an essential resource for professionals keen on advancing their knowledge in this critical area of medicine, fostering innovations that ultimately improve patient care.

Clinical Hypertension

Unlocking the future of hypertension science.
Publisher: SPRINGERNATUREISSN: Frequency: 1 issue/year

Clinical Hypertension is a premier journal dedicated to advancing the field of hypertension and cardiovascular health, published by SpringerNature. Since its transition to an Open Access model in 2014, the journal has opened doors for researchers globally to share their findings without barriers, aiming to foster collaboration and innovation in this vital area of medicine. With a current impact factor that positions it in the Q2 quartile for both Cardiology and Cardiovascular Medicine and Internal Medicine, Clinical Hypertension is recognized for its scholarly contributions, reflected in its Scopus rankings (Rank #100/387 in Cardiology and Rank #52/167 in Internal Medicine), which place it in the top percentiles of these competitive fields. Covering a diverse range of topics within hypertension research, it serves as an essential resource for clinicians, researchers, and students alike, promising to keep its audience informed of the latest developments and breakthroughs from its inception in 2017 through to 2024.

Hypertension Research in Pregnancy

Transforming care for mothers and babies through rigorous research.
Publisher: JAPAN SOC STUDY HYPERTENSION PREGNANCYISSN: 2187-5987Frequency: 2 issues/year

Hypertension Research in Pregnancy is a specialized journal dedicated to advancing the understanding of hypertension during pregnancy, an area critical for both maternal and fetal health. Published by the Japan Society for the Study of Hypertension in Pregnancy, this journal serves as a platform for researchers, clinicians, and healthcare professionals who are committed to improving outcomes in this vital field. Although currently not an open-access publication, Hypertension Research in Pregnancy disseminates rigorous scientific research and reviews that forge a path for innovative therapeutic strategies and clinical practices. With an emphasis on the latest findings and methodological advancements, the journal aims to address key challenges and promote best practices in care for hypertensive disorders in pregnancy. As a repository of knowledge and a catalyst for collaboration, it plays a crucial role in shaping future research directions and clinical interventions, making it an essential resource for anyone involved in obstetric care and maternal-fetal medicine.

Integrated Blood Pressure Control

Advancing Blood Pressure Management for Better Health
Publisher: DOVE MEDICAL PRESS LTDISSN: 1178-7104Frequency: 1 issue/year

Integrated Blood Pressure Control is a distinguished Open Access journal published by DOVE MEDICAL PRESS LTD in New Zealand, dedicated to advancing the field of cardiology and cardiovascular medicine as well as internal medicine. With its established timeline from 2009 to 2024, this journal has earned a commendable Q2 ranking in both its categories for 2023, reflecting its significant contribution to clinical research and practice. With an ISSN of 1178-7104, it provides a platform for high-quality, peer-reviewed articles that address the complexities of blood pressure management, aiming to improve patient outcomes and foster discussions among healthcare professionals. The journal's open-access model, implemented since 2008, ensures that research findings are readily available to all, promoting greater accessibility and dissemination of knowledge in this critical area of health. Researchers, professionals, and students alike are encouraged to engage with the latest findings and innovative practices published within this journal, which plays an essential role in shaping the future of blood pressure control and related medical fields.

CLINICAL AND EXPERIMENTAL HYPERTENSION

Uncovering breakthroughs in hypertension studies.
Publisher: TAYLOR & FRANCIS INCISSN: 1064-1963Frequency: 8 issues/year

Clinical and Experimental Hypertension, published by Taylor & Francis Inc, is a crucial resource in the fields of internal medicine and physiology. With its inaugural publication dating back to 1978, this esteemed journal has successfully merged decades of research, providing a platform for the latest advancements in hypertension studies. Operating without an open access model, it is configured to serve a specialized audience of researchers, clinicians, and students who are dedicated to exploring innovative treatment modalities and understanding the complexities of hypertensive diseases. Ranked in the Q3 category in both Internal Medicine and Physiology, this journal accomplishes a commendable standing in the academic community, exemplified by its Scopus rankings which position it within the median percentile range in its field. By disseminating high-quality research and fostering scientific dialogue, Clinical and Experimental Hypertension plays a pivotal role in shaping contemporary understanding and clinical practices concerning hypertension management.

Arterial Hypertension

Connecting disciplines for a comprehensive understanding of hypertension.
Publisher: VIA MEDICAISSN: 2449-6170Frequency: 4 issues/year

Arterial Hypertension is a dedicated Open Access journal published by VIA MEDICA, with the ISSN 2449-6170 and E-ISSN 2449-6162, focusing on the multidisciplinary field of cardiology, endocrinology, and internal medicine. Established in Poland, this journal has been providing researchers and healthcare professionals with accessible, high-quality content since its inception in 1999. With a commitment to advancing knowledge in the management and treatment of arterial hypertension, it publishes significant research findings, clinical trials, and reviews that contribute to improved health outcomes. Though classified in Q4 across various relevant categories, the continuous improvement in its content ensures its relevance in an evolving medical landscape. Designed to facilitate collaboration and innovation, Arterial Hypertension serves as a crucial resource for anyone invested in cardiovascular health, encouraging open dialogue and dissemination of vital research within the scientific community.

Journal of Diabetes Investigation

Exploring the frontiers of diabetes and metabolism.
Publisher: WILEYISSN: 2040-1116Frequency: 6 issues/year

Journal of Diabetes Investigation is a prestigious open-access journal published by WILEY, dedicated to advancing knowledge in the fields of Endocrinology, Diabetes, and Metabolism. With its ISSN 2040-1116 and E-ISSN 2040-1124, the journal provides a vital platform for researchers, healthcare professionals, and students to disseminate high-quality research, foster innovative ideas, and engage with cutting-edge developments in diabetes investigation. Since its inception in 2010, the journal has established a solid reputation, ranking in Q2 for Endocrinology and Diabetes and Metabolism, and Q1 for both Internal Medicine and Miscellaneous Medicine categories in 2023. Its Scopus rankings further underscore its impact, notably at the 76th percentile in Internal Medicine. The open access model, adopted in 2014, ensures that vital information is freely available, promoting global collaboration and knowledge sharing. The journal is not only a reflection of Australia's commitment to medical research but also a beacon for advancements that can ultimately enhance patient outcomes in diabetes care.

Saudi Journal of Kidney Diseases and Transplantation

Unlocking new frontiers in kidney disease management.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1319-2442Frequency: 6 issues/year

Saudi Journal of Kidney Diseases and Transplantation, published by Wolters Kluwer Medknow Publications, serves as a vital resource in the fields of nephrology and transplantation, dedicated to advancing the understanding and treatment of kidney diseases. With an ISSN of 1319-2442 and E-ISSN 2320-3838, this esteemed peer-reviewed journal aims to facilitate scholarly exchange and promote innovative research since its inception in 2006. Recognized for its Open Access model since 2007, it enables widespread dissemination of critical findings, thereby enhancing the global impact of kidney-related research. With a solid reputation reflected in its current Q3 categorization in both Nephrology and Transplantation for 2023, the journal continues to contribute meaningfully to these essential medical fields. Researchers, clinical professionals, and students can access its wealth of information to further their knowledge and practice in kidney health and organ transplantation, vital components in the landscape of modern medicine.

KIDNEY & BLOOD PRESSURE RESEARCH

Pioneering Research for a Healthier Tomorrow.
Publisher: KARGERISSN: 1420-4096Frequency: 12 issues/year

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

Current Hypertension Reviews

Pioneering Knowledge in Cardiovascular Disorders
Publisher: BENTHAM SCIENCE PUBL LTDISSN: 1573-4021Frequency:

Current Hypertension Reviews, published by Bentham Science Publishers Ltd, stands as a leading journal in the field of internal medicine, particularly focusing on hypertension and related cardiovascular disorders. With an impressive impact factor and ranked #59 out of 167 in the Scopus medicine category, this journal highlights key insights and contemporary research trends from its inception in 2006 to 2024. Its commitment to making high-quality research accessible to the medical community, despite lacking an Open Access option, ensures that it continues to contribute significantly to the scientific discourse surrounding hypertension management and innovative treatments. Researchers, clinicians, and students alike will find valuable resources within its pages, as Current Hypertension Reviews plays a critical role in advancing the understanding and treatment of hypertension, ultimately supporting better health outcomes globally.